Plasma Technologies, LLC
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1
Ending by 2030
Jul 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 3 fees due Feb 8 to 28, 2027 · next Feb 8
- 1 fee due Mar 19, 2027The maintenance fee for Compositions and Methods for High Efficiency Protein Precipitation (US 11,760,778) comes due Mar 19, 2027. Unpaid by Sep 20, 2027, it lapses early.
- 1 fee due Jul 30, 2027The maintenance fee for Systems and Methods for Process Scale Isolation of Immunoglobulin G (US 11,884,702) comes due Jul 30, 2027. Unpaid by Jan 31, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,879,332 | Ultra-high yield intravenous immune globulin preparation In force · From the USPTO record | In force | From the USPTO record | |
| US 10,809,247 | Methods for Extracting Proteins from Blood Plasma In force · High confidence | In force | High confidence | |
| US 11,719,690 | Methods for Extracting A1P1 and Albumin from Blood Plasma In force · High confidence | In force | High confidence | |
| US 12,180,250 | Methods for Extracting Proteins from a Blood-Based Material In force · High confidence | In force | High confidence | |
| US 11,028,125 | Methods for Extracting Proteins from a Blood-Based Material In force · High confidence | In force | High confidence | |
| US 10,815,270 | Compositions and Methods for High Efficiency Protein Precipitation In force · High confidence | In force | High confidence | |
| US 10,836,790 | Therapeutic protein compositions and methods In force · From the USPTO record | In force | From the USPTO record | |
| US 11,739,117 | Therapeutic protein compositions and methods In force · From the USPTO record | In force | From the USPTO record | |
| US 11,760,778 | Compositions and Methods for High Efficiency Protein Precipitation In force · Medium confidence | In force | Medium confidence | |
| US 11,732,004 | Compositions and methods for simplified high efficiency isolation of proteins In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 12: 1 patent in force now held by others · 1 lapsed for an unpaid fee · 3 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending · 1 abandoned · 2 no status recorded